Cargando…
Oncogenic lesions and molecular subtypes in adults with B‐cell acute lymphoblastic leukemia
B‐cell acute lymphoblastic leukemia (B‐ALL), a genetically heterogeneous disease, is classified into different molecular subtypes that are defined by recurrent gene rearrangements, gross chromosomal abnormalities, or specific gene mutations. Cells with these genetic alterations acquire a leukemia‐in...
Autores principales: | Yasuda, Takahiko, Sanada, Masashi, Tsuzuki, Shinobu, Hayakawa, Fumihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807527/ https://www.ncbi.nlm.nih.gov/pubmed/36106363 http://dx.doi.org/10.1111/cas.15583 |
Ejemplares similares
-
BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia
por: Tsuzuki, Shinobu, et al.
Publicado: (2022) -
Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP‐IGH fusion gene
por: Odaira, Koya, et al.
Publicado: (2022) -
Molecular Detection of Fusion Oncogenes in Zambian Patients with Acute Lymphoblastic Leukemia
por: Okuku, Pauline, et al.
Publicado: (2020) -
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases
por: Dai, Yu-Ting, et al.
Publicado: (2022) -
Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia
por: Mäkinen, Ville-Petteri, et al.
Publicado: (2022)